Electroacupuncture on Treating Cancer-related Depression

Cancer-related depression (CRD) is a common psychological condition among cancer patients during diagnosis, treatment, and recovery, and is associated with reduced quality of life, impaired immune function, and poorer clinical outcomes. As cancer incidence and mortality continue to rise in China, the psychological burden on patients is receiving increasing attention. Electroacupuncture (EA) has shown potential in treating various types of depression and related somatic symptoms, but evidence regarding its efficacy, safety, and long-term effects in CRD remains limited. This randomized controlled trial aims to evaluate the short- and long-term efficacy and safety of EA for CRD, with the goal of providing evidence to support effective and optimized treatment strategies.

NCT Number	NCT07003763
Lead Sponsor	Shanghai Municipal Hospital of Traditional Chinese Medicine
Conditions	Depression, Cancer
Enrollment	86 participants
Start Date	2025-07-01
Primary Completion	2026-12-31 (estimated)
Study Completion	2027-07-01 (estimated)
Updated on ClinicalTrials.gov	2025-12-23